219A.T
Heartseed Inc.
グロース · 医薬品 · 医薬品 · JP
JPY 2,172.00
−2.29%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +0.0%
- EBITDA
- —
- EPS
- -44.9%
Three-year CAGR
- Revenue
- +246.6%
- EBITDA
- +132.6%
- EBIT
- +126.2%
- Net income
- +123.4%
- EPS
- +117.1%
- Free cash flow
- +177.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026